gs-0976
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2015 (NCT02876796)
Timeline
Indications
Mechanism of action
- Acetyl-CoA carboxylaseINHIBITOR
Acetyl-CoA carboxylase inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gs-0976
- gs-0976
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02891408 | Phase 1 | Sep 1, 2016 | Gilead Sciences |
| NCT02856555 | Phase 2 | Aug 8, 2016 | Gilead Sciences |
| NCT02781584 | Phase 2 | Jul 13, 2016 | Gilead Sciences |
| NCT02876796 | Phase 1 | Aug 1, 2015 | Gilead Sciences, Nimbus Apollo |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gilead Sciences | For profit | 4 | 4 | 2 | 2015 |
| Nimbus Apollo | For profit | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1